BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li C, Xu X, Wei S, Jiang P, Xue L, Wang J; Senior Correspondence. Tumor-associated macrophages: potential therapeutic strategies and future prospects in cancer. J Immunother Cancer 2021;9:e001341. [PMID: 33504575 DOI: 10.1136/jitc-2020-001341] [Cited by in Crossref: 2] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Chang Z, Zhang Q, Hu Q, Liu Y, Zhang L, Liu R. Tannins in Terminalia bellirica inhibits hepatocellular carcinoma growth via re-educating tumor-associated macrophages and restoring CD8+T cell function. Biomedicine & Pharmacotherapy 2022;154:113543. [DOI: 10.1016/j.biopha.2022.113543] [Reference Citation Analysis]
2 Zhuo S, Yang L, Chen S, Tang C, Li W, Gao Z, Feng J, Yang K. Ferroptosis: A potential opportunity for intervention of pre-metastatic niche. Front Oncol 2022;12:980620. [DOI: 10.3389/fonc.2022.980620] [Reference Citation Analysis]
3 Cismaru CA, Pirlog R, Calin GA, Berindan-Neagoe I. Stem Cells in the Tumor Immune Microenvironment -Part of the Cure or Part of the Disease? Ontogeny and Dichotomy of Stem and Immune Cells has Led to better Understanding. Stem Cell Rev Rep 2022. [PMID: 35841518 DOI: 10.1007/s12015-022-10428-7] [Reference Citation Analysis]
4 Wallace-Povirk A, Rubinsak L, Malysa A, Dzinic SH, Ravindra M, Schneider M, Glassbrook J, O'Connor C, Hou Z, Kim S, Back J, Polin L, Morris RT, Gangjee A, Gibson H, Matherly LH. Targeted therapy of pyrrolo[2,3-d]pyrimidine antifolates in a syngeneic mouse model of high grade serous ovarian cancer and the impact on the tumor microenvironment. Sci Rep 2022;12:11346. [PMID: 35790779 DOI: 10.1038/s41598-022-14788-5] [Reference Citation Analysis]
5 Bi Q, Wu JY, Qiu XM, Zhang JD, Sun ZJ, Wang W. Tumor-Associated Inflammation: The Tumor-Promoting Immunity in the Early Stages of Tumorigenesis. J Immunol Res 2022;2022:3128933. [PMID: 35733919 DOI: 10.1155/2022/3128933] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang Y, Long Y, Wan J, Liu S, Shi A, Li D, Yu S, Li X, Wen J, Deng J, Ma Y, Li N. Macrophage Membrane Biomimetic Drug Delivery System: for Inflammation Targeted Therapy. J Drug Target 2022;:1-47. [PMID: 35587560 DOI: 10.1080/1061186X.2022.2071426] [Reference Citation Analysis]
7 Wang Y, Huang Z, Li B, Liu L, Huang C. The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer. Front Endocrinol 2022;13:863541. [DOI: 10.3389/fendo.2022.863541] [Reference Citation Analysis]
8 Liu K, Cui J, Zhan Y, Ouyang Q, Lu Q, Yang D, Li X, Yin J. Reprogramming the tumor microenvironment by genome editing for precision cancer therapy. Mol Cancer 2022;21. [DOI: 10.1186/s12943-022-01561-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Andrea AE, Chiron A, Mallah S, Bessoles S, Sarrabayrouse G, Hacein-Bey-Abina S. Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment. Front Immunol 2022;13:830292. [PMID: 35211124 DOI: 10.3389/fimmu.2022.830292] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Wang S, Yang Y, Ma P, Huang H, Tang Q, Miao H, Fang Y, Jiang N, Li Y, Zhu Q, Tao W, Zha Y, Li N. Landscape and perspectives of macrophage -targeted cancer therapy in clinical trials. Mol Ther Oncolytics 2022;24:799-813. [PMID: 35317518 DOI: 10.1016/j.omto.2022.02.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Qiu X, Zhao T, Luo R, Qiu R, Li Z. Tumor-Associated Macrophages: Key Players in Triple-Negative Breast Cancer. Front Oncol 2022;12:772615. [DOI: 10.3389/fonc.2022.772615] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Conte E. Targeting monocytes/macrophages in fibrosis and cancer diseases: Therapeutic approaches. Pharmacol Ther 2021;:108031. [PMID: 34774879 DOI: 10.1016/j.pharmthera.2021.108031] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Xu M, Wang Y, Xia R, Wei Y, Wei X. Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting. Cell Prolif 2021;54:e13115. [PMID: 34464477 DOI: 10.1111/cpr.13115] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
14 Tan Y, Wang M, Zhang Y, Ge S, Zhong F, Xia G, Sun C. Tumor-Associated Macrophages: A Potential Target for Cancer Therapy. Front Oncol 2021;11:693517. [PMID: 34178692 DOI: 10.3389/fonc.2021.693517] [Cited by in F6Publishing: 13] [Reference Citation Analysis]